Perk heterozygosity ameliorates chronic hypoxia-induced pulmonary hypertension and right ventricular hypertrophy in male rats

Qingxia Wei, Hanlu Li, Yibing Chen, Xiang Xu, Ge Guo, Xin Li, Yanying Shen, Chunlei Liu, Kunlun HeClinical 2021 · DOI

Abstract

These findings suggest that <i>Perk</i> heterozygosity protects against HPH and <i>Perk</i> may be a suitable target for treating HPH.
BibTeX
@inproceedings{wei2021i,
  author = {Qingxia Wei and Hanlu Li and Yibing Chen and Xiang Xu and Ge Guo and Xin Li and Yanying Shen and Chunlei Liu and Kunlun He},
  title = {{<i>Perk</i> heterozygosity ameliorates chronic hypoxia-induced pulmonary hypertension and right ventricular hypertrophy in male rats}},
  booktitle = {Clinical},
  year = {2021},
  doi = {10.1080/10641963.2021.1984501},
}

Loading related content...

Figure